Clene Inc. (NASDAQ: CLNN)
$4.94
-0.0600 ( -1.20% ) 33.7K
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
Market Data
Open
$4.94
Previous close
$5.00
Volume
33.7K
Market cap
$31.53M
Day range
$4.90 - $5.06
52 week range
$4.59 - $17.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 31, 2024 |
4 | Insider transactions | 1 | May 31, 2024 |
8-k | 8K-related | 16 | May 30, 2024 |
8-k | 8K-related | 15 | May 08, 2024 |
10-q | Quarterly Reports | 87 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
8-k | 8K-related | 16 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 17, 2024 |
def | Proxies and info statements | 8 | Apr 16, 2024 |